Cargando…
Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors
A class of tripeptidyl transition state inhibitors containing a P1 glutamine surrogate, a P2 leucine, and a P3 arylalanines, was found to potently inhibit Norwalk virus replication in enzyme and cell based assays. An array of warheads, including aldehyde, α-ketoamide, bisulfite adduct, and α-hydroxy...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863581/ https://www.ncbi.nlm.nih.gov/pubmed/24125888 http://dx.doi.org/10.1016/j.bmcl.2013.09.070 |
_version_ | 1782295840645185536 |
---|---|
author | Prior, Allan M. Kim, Yunjeong Weerasekara, Sahani Moroze, Meghan Alliston, Kevin R. Uy, Roxanne Adeline Z. Groutas, William C. Chang, Kyeong-Ok Hua, Duy H. |
author_facet | Prior, Allan M. Kim, Yunjeong Weerasekara, Sahani Moroze, Meghan Alliston, Kevin R. Uy, Roxanne Adeline Z. Groutas, William C. Chang, Kyeong-Ok Hua, Duy H. |
author_sort | Prior, Allan M. |
collection | PubMed |
description | A class of tripeptidyl transition state inhibitors containing a P1 glutamine surrogate, a P2 leucine, and a P3 arylalanines, was found to potently inhibit Norwalk virus replication in enzyme and cell based assays. An array of warheads, including aldehyde, α-ketoamide, bisulfite adduct, and α-hydroxyphosphonate transition state mimic, was also investigated. Tripeptidyls 2 and 6 possess antiviral activities against noroviruses, human rhinovirus, severe acute respiratory syndrome coronavirus, and coronavirus 229E, suggesting a broad range of antiviral activities. |
format | Online Article Text |
id | pubmed-3863581 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-38635812014-12-01 Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors Prior, Allan M. Kim, Yunjeong Weerasekara, Sahani Moroze, Meghan Alliston, Kevin R. Uy, Roxanne Adeline Z. Groutas, William C. Chang, Kyeong-Ok Hua, Duy H. Bioorg Med Chem Lett Article A class of tripeptidyl transition state inhibitors containing a P1 glutamine surrogate, a P2 leucine, and a P3 arylalanines, was found to potently inhibit Norwalk virus replication in enzyme and cell based assays. An array of warheads, including aldehyde, α-ketoamide, bisulfite adduct, and α-hydroxyphosphonate transition state mimic, was also investigated. Tripeptidyls 2 and 6 possess antiviral activities against noroviruses, human rhinovirus, severe acute respiratory syndrome coronavirus, and coronavirus 229E, suggesting a broad range of antiviral activities. Elsevier Ltd. 2013-12-01 2013-09-30 /pmc/articles/PMC3863581/ /pubmed/24125888 http://dx.doi.org/10.1016/j.bmcl.2013.09.070 Text en Copyright © 2013 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Prior, Allan M. Kim, Yunjeong Weerasekara, Sahani Moroze, Meghan Alliston, Kevin R. Uy, Roxanne Adeline Z. Groutas, William C. Chang, Kyeong-Ok Hua, Duy H. Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors |
title | Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors |
title_full | Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors |
title_fullStr | Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors |
title_full_unstemmed | Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors |
title_short | Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors |
title_sort | design, synthesis, and bioevaluation of viral 3c and 3c-like protease inhibitors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863581/ https://www.ncbi.nlm.nih.gov/pubmed/24125888 http://dx.doi.org/10.1016/j.bmcl.2013.09.070 |
work_keys_str_mv | AT priorallanm designsynthesisandbioevaluationofviral3cand3clikeproteaseinhibitors AT kimyunjeong designsynthesisandbioevaluationofviral3cand3clikeproteaseinhibitors AT weerasekarasahani designsynthesisandbioevaluationofviral3cand3clikeproteaseinhibitors AT morozemeghan designsynthesisandbioevaluationofviral3cand3clikeproteaseinhibitors AT allistonkevinr designsynthesisandbioevaluationofviral3cand3clikeproteaseinhibitors AT uyroxanneadelinez designsynthesisandbioevaluationofviral3cand3clikeproteaseinhibitors AT groutaswilliamc designsynthesisandbioevaluationofviral3cand3clikeproteaseinhibitors AT changkyeongok designsynthesisandbioevaluationofviral3cand3clikeproteaseinhibitors AT huaduyh designsynthesisandbioevaluationofviral3cand3clikeproteaseinhibitors |